{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/06/3340279/0/en/Vistagen-Announces-Topline-Results-for-Repeat-Dose-Study-of-Fasedienol-for-Acute-Treatment-of-Social-Anxiety-Disorder.html", "message": "News view counter 868199 successfully enlarged"}